QA

Qianhai Ark

Description

Qianhai Ark

Investor Profile

Qianhai Ark has made 5 investments, with 3 in the past 12 months and 40% as lead.

Stage Focus

  • Series A (60%)
  • Series E (20%)
  • Series B (20%)

Country Focus

  • China (80%)
  • United States (20%)

Industry Focus

  • Manufacturing
  • Advanced Materials
  • Biopharma
  • Biotechnology
  • Therapeutics
  • Medical
  • Medical Device
  • Robotics
  • Sensor
  • Data Storage
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qianhai Ark frequently co-invest with?

Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 1
Ascletis
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
GLP Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Guolian Securities
Asia, Anhui, China, Wuxi
Co-Investments: 1
Huaneng Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Sherpa Healthcare Partners
Asia, Beijing, China, Beijing
Co-Investments: 1
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Qianhai Ark?

FDMTEK

Haidian, Beijing, China

Zhongke Benyuan manufactures digital signal processor (DSP) chips.

Data StorageManufacturing
Series BMar 13, 2025
Kunwei Technology

Changzhou, Zhejiang, China

Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems.

ManufacturingSensor
Series AJan 8, 2025
Aoda Zhisheng

Beijing, Beijing, China

Aoda Zhisheng provides clinical robot systems, technology, and smart medical comprehensive solutions.

MedicalMedical DeviceRobotics
Series ANov 1, 2024
Riyu Photovoltaic

Wuxi Shi, Jiangsu, China

Riyu Photovoltaic specializes in the development of solar cell front silver paste materials.

Advanced MaterialsManufacturing
Series AAug 27, 2023
Amount Raised: $13,717,421
Sagimet Biosciences

San Mateo, California, United States

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

BiopharmaBiotechnologyTherapeutics
Series EAug 5, 2019
Amount Raised: $7,000,000